MolMed S.p.A. | Key People and Executives
Claudio Bordignon
Chairman
Riccardo Palmisano
Chief Executive Officer & Director
Alberto Luigi Carletti
Director
Elizabeth Marie Robinson
Independent Director
Didier Trono
Independent Director
Carlo Incerti
Independent Director
Laura Iris Ferro
Independent Director
Raffaella Ruggiero
Independent Director
Mario Masciocchi
Lead Independent Director
Claudio Bordignon
Chairman
Riccardo Palmisano
Chief Executive Officer & Director
Simona Rovetta
Operations Director
Andrea Quaglino
CFO, Director-Administration & Control
Tiziano Andreoli
Director-Information Technology
Catia Traversari
Research Director
Antonio Lambiase
Director-Clinical Development
Luca Alberici
Chief Business Officer
Marco Manoni
Director-Facility Planning & Design
Alberto Luigi Carletti
Director
Ilaria Candotti
Manager-Investor Relations & Communications
Cynthia Marina Giuliani
Director-Human Resources & General Services
Silvia Pisante
Head-Legal Affairs & Corporate Governance
Elizabeth Marie Robinson
Independent Director
Didier Trono
Independent Director
Carlo Incerti
Independent Director
Laura Iris Ferro
Independent Director
Raffaella Ruggiero
Independent Director
Mario Masciocchi
Lead Independent Director
| Address |
Via Olgettina, 58
Milan Milan 20132
Italy
|
|
Employees
|
- |
| Website |
http://www.molmed.it |
| Updated |
09/14/2018 |
| Molecular Medicine SpA is a medical biotechnology company which focuses on the research, development and clinical validation of therapies to treat cancer. The company's approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. Its pipeline includes antitumor therapeutics in clinical and preclinical development: Zalmoxis (TK) is a cell-based therapy enabling bone marrow transplants from partially compatible donors, in absence of post-transplant immune-suppression. |
